A REVIEW OF BCR ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASM WITH DENTAL IMPLICATIONS
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
BCR-ABL1 negative myeloproliferative neoplasms (MPN) primarily include: Essential thrombocythemia (ET), Polycythemia vera (PV), and Primary myelofibrosis (PMF). They are considered rare hematological malignancies. Lately, with ongoing advances in the field of genetics and molecular biology, more clarity has been achieved on the pathogenesis of these disorders and many advances are being made in the diagnosis, prognostic evaluation and treatment of these malignancies. These disorders have oral manifestations and also present a significant risk of bleeding and thrombosis after dental procedures if proper precautions and care are not taken. This article highlights important aspects of these disorders including oral manifestations and dental care.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.